AI Revolution in Healthcare: Viome's At-home Cancer Test & Microsoft's Revenue Solutions - Life AI Weekly #25

Hi there,

In this edition of Life AI Weekly, we're diving into the latest advancements in healthcare and life sciences AI. Divamics is making strides in drug discovery for metabolic diseases using AI technology, while Elix and LINC have teamed up to launch a new AI drug discovery platform. These developments highlight the growing role of AI in revolutionizing the way we approach drug discovery and development.

Additionally, Viome and Scripps Research have collaborated to create an at-home RNA test for colon cancer, showcasing the potential of AI in early disease detection. Meanwhile, Omega Healthcare and Microsoft are launching AI solutions aimed at improving revenue management in healthcare. These stories reflect the ongoing integration of AI technologies in healthcare, promising to enhance both patient outcomes and operational efficiencies.

FluidAI Medical has received a $2 million investment from the Government of Canada to further develop its AI-driven postoperative care technology. Zimmer Biomet Holdings, Inc. plans to acquire Monogram Technologies Inc. for $177 million to boost its orthopedic robotics capabilities.

Divamics has announced its involvement in drug discovery for metabolic diseases, utilizing AI to enhance receptor binding and drug efficacy. The company is advancing its drug BGM0504 into Phase III trials. Elix and the Life Intelligence Consortium have launched an AI drug discovery platform using federated learning, involving data from 16 pharmaceutical companies.

The Jackson Laboratory and The New York Stem Cell Foundation have formed a partnership to enhance disease research and therapy discovery, focusing on conditions like Alzheimer's and cancer. ScienceMachine, a London-based AI startup, has raised $3.5 million in pre-seed funding to develop its autonomous AI agent for biotech and pharma data analysis.

Viome Life Sciences and Scripps Research have partnered to create an at-home RNA screening test for detecting precancerous colon polyps. Omega Healthcare and Microsoft have launched over 20 AI solutions for revenue cycle management. SimBioSys received its third FDA clearance for TumorSight™ Viz, enhancing breast cancer surgery with AI-driven 3D visualizations.